PCTC
CVS icon

Perkins Coie Trust Company’s CVS Health CVS Stock Holding History

Perkins Coie Trust Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-900
Closed -$62.1K – 303
2025
Q2 		$62.1K Hold
900
– – 0.01% 177
2025
Q1 		$61K Sell
900
-69
-7% -$4.13K 0.01% 170
2024
Q4 		$43.5K Sell
969
-548
-36% -$30.7K 0.01% 187
2024
Q3 		$95.4K Sell
1,517
-1,273
-46% -$74.3K 0.02% 159
2024
Q2 		$165K Sell
2,790
-35,231
-93% -$2.2M 0.04% 120
2024
Q1 		$3.03M Sell
38,021
-159
-0.4% -$12.1K 0.71% 50
2023
Q4 		$3.01M Sell
38,180
-10,811
-22% -$769K 0.76% 47
2023
Q3 		$3.42M Buy
48,991
+2,009
+4% +$142K 0.97% 34
2023
Q2 		$3.25M Buy
46,982
+1,081
+2% +$76.9K 0.92% 37
2023
Q1 		$3.41M Buy
45,901
+1,098
+2% +$92.1K 1.02% 36
2022
Q4 		$4.18M Buy
44,803
+271
+0.6% +$26.1K 1.33% 25
2022
Q3 		$4.25M Buy
44,532
+171
+0.4% +$16.9K 1.63% 17
2022
Q2 		$4.11M Buy
44,361
+857
+2% +$83.6K 1.5% 24
2022
Q1 		$4.4M Sell
43,504
-1,842
-4% -$194K 1.37% 28
2021
Q4 		$4.68M Buy
45,346
+2,212
+5% +$204K 1.37% 25
2021
Q3 		$3.66M Buy
43,134
+179
+0.4% +$15K 1.15% 36
2021
Q2 		$3.58M Buy
42,955
+825
+2% +$67.6K 1.1% 37
2021
Q1 		$3.17M Buy
42,130
+618
+1% +$45K 1.06% 38
2020
Q4 		$2.83M Buy
41,512
+1,141
+3% +$74.2K 0.97% 42
2020
Q3 		$2.36M Buy
40,371
+2,029
+5% +$126K 0.94% 40
2020
Q2 		$2.49M Buy
38,342
+4,231
+12% +$266K 1.02% 40
2020
Q1 		$2.02M Sell
34,111
-49
-0.1% -$3.27K 1.03% 40
2019
Q4 		$2.54M Buy
34,160
+4,625
+16% +$325K 1.04% 40
2019
Q3 		$1.86M Sell
29,535
-210
-0.7% -$12.4K 0.82% 50
2019
Q2 		$1.62M Sell
29,745
-343
-1% -$18.5K 0.74% 52
2019
Q1 		$1.62M Buy
30,088
+836
+3% +$51.6K 0.75% 51
2018
Q4 		$1.92M Buy
29,252
+22
+0.1% +$1.64K 1% 39
2018
Q3 		$2.3M Sell
29,230
-146
-0.5% -$10.4K 1.07% 37
2018
Q2 		$1.89M Buy
29,376
+652
+2% +$43K 0.93% 43
2018
Q1 		$1.79M Buy
28,724
+1,244
+5% +$89.3K 0.89% 44
2017
Q4 		$1.99M Buy
27,480
+196
+0.7% +$14.3K 0.99% 41
2017
Q3 		$2.22M Buy
27,284
+543
+2% +$43K 1.15% 32
2017
Q2 		$2.15M Buy
26,741
+1,948
+8% +$154K 1.16% 32
2017
Q1 		$1.95M Buy
24,793
+186
+0.8% +$14.8K 1.14% 35
2016
Q4 		$1.94M Sell
24,607
-359
-1% -$29K 1.18% 34
2016
Q3 		$2.22M Buy
24,966
+880
+4% +$83.1K 1.41% 28
2016
Q2 		$2.31M Buy
24,086
+1,294
+6% +$129K 1.52% 22
2016
Q1 		$2.36M Sell
22,792
-1,470
-6% -$143K 1.61% 16
2015
Q4 		$2.37M Buy
24,262
+232
+1% +$22.7K 1.78% 12
2015
Q3 		$2.32M Sell
24,030
-230
-0.9% -$24.2K 1.87% 9
2015
Q2 		$2.54M Sell
24,260
-192
-0.8% -$19.6K 1.92% 7
2015
Q1 		$2.52M Buy
24,452
+71
+0.3% +$7.18K 1.94% 7
2014
Q4 		$2.35M Buy
24,381
+450
+2% +$39.6K 1.87% 12
2014
Q3 		$1.91M Buy
23,931
+402
+2% +$31.7K 1.6% 26
2014
Q2 		$1.77M Sell
23,529
-2,277
-9% -$172K 1.66% 28
2014
Q1 		$1.93M Sell
25,806
-277
-1% -$19.6K 1.86% 18
2013
Q4 		$1.87M Buy
+26,083
New +$1.68M 1.84% 17

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Perkins Coie Trust Company's CVS Position: Q3 2025 in Review

Perkins Coie Trust Company sold out of CVS Health (CVS) in Q3 2025, closing a stake of 900 shares — an estimated $62.1K sold.

Perkins Coie Trust Company first reported a position in CVS in Q4 2013 and held it in 47 quarters. The position peaked at $4.68M in Q4 2021. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Perkins Coie Trust Company reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
  • Perkins Coie Trust Company sold 900 CVS Health shares in Q3 2025, an estimated $62.1K.
  • Perkins Coie Trust Company first reported a position in CVS Health in Q4 2013 and held it in 47 quarters.
  • Perkins Coie Trust Company's CVS Health position peaked at $4.68M in Q4 2021.
  • 1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Perkins Coie Trust Company's 13F filing for Q3 2025, filed 9 Oct 2025.